MEROTIX 125

Composition: Meropenem 125 mg
Packing: 1 vial
Dosage Form: Parenteral-Dry Injection
DPCO

Description

Composition- Meropenem 125 mg

Mode of Action- Inhibits bacterial cell wall synthesis and provides potent bactericidal activity against a wide range of susceptible pathogens.

USPs- Lower strength injectable option; broad-spectrum antibacterial coverage; useful in hospital-based infection management.

Prescribing Specialties- Pediatrician, Physician